BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1697781)

  • 41. Characterization of an anti-idiotypic MoAb bearing an internal image of the receptor-binding epitope of cholera toxin.
    Lucas GP; Cambiaso CL; Vaerman JP
    Clin Exp Immunol; 1992 Sep; 89(3):378-83. PubMed ID: 1381299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of cholera toxin B subunit to intestinal epithelial cells.
    Navolotskaya EV; Sadovnikov VB; Lipkin VM; Zav'yalov VP
    Toxicol In Vitro; 2018 Mar; 47():269-273. PubMed ID: 29262310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Granulosa cell luteinizing hormone receptor expression is modulated by ganglioside-specific ligands.
    Hattori M; Kanzaki M; Kojima I; Horiuchi R
    Biochim Biophys Acta; 1994 Mar; 1221(1):47-53. PubMed ID: 8130275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding of cholera toxin to mucins and inhibition by gastric mucin.
    Strombeck DR; Harrold D
    Infect Immun; 1974 Dec; 10(6):1266-72. PubMed ID: 4435956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of choleragen and anti-ganglioside antibodies to gangliosides incorporated into preformed liposomes.
    Richards RL; Fishman PH; Moss J; Alving CR
    Biochim Biophys Acta; 1983 Sep; 733(2):249-55. PubMed ID: 6882761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solution dynamics of the oligosaccharide moiety of ganglioside GM1: comparison of solution conformations with the bound state conformation in association with cholera toxin B-pentamer.
    Richardson JM; Milton MJ; Homans SW
    J Mol Recognit; 1995; 8(6):358-62. PubMed ID: 9052976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intoxication of cultured cells by cholera toxin: evidence for different pathways when bound to ganglioside GM1 or neoganglioproteins.
    Pacuszka T; Fishman PH
    Biochemistry; 1992 May; 31(20):4773-8. PubMed ID: 1317209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of cholera toxin and Escherichia coli enterotoxin with isolated intestinal epithelial cells.
    Hyun CS; Kimmich GA
    Am J Physiol; 1984 Dec; 247(6 Pt 1):G623-31. PubMed ID: 6095676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorescence analysis of galactose, lactose, and fucose interaction with the cholera toxin B subunit.
    Mertz JA; McCann JA; Picking WD
    Biochem Biophys Res Commun; 1996 Sep; 226(1):140-4. PubMed ID: 8806604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of cholera toxin-binding sites in the nucleus of intestinal epithelial cells.
    Parkinson ME; Smith CG; Garland PB; van Heyningen S
    FEBS Lett; 1989 Jan; 242(2):309-13. PubMed ID: 2914613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules.
    Wolf AA; Jobling MG; Saslowsky DE; Kern E; Drake KR; Kenworthy AK; Holmes RK; Lencer WI
    Infect Immun; 2008 Apr; 76(4):1476-84. PubMed ID: 18212085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variation in epitopes of the B subunit of El Tor and classical biotype Vibrio cholerae O1 cholera toxin.
    Tamplin ML; Ahmed MK; Jalali R; Colwell RR
    J Gen Microbiol; 1989 May; 135(5):1195-200. PubMed ID: 2482860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemical and immunochemical studies on the receptor binding domain of cholera toxin B subunit.
    Ludwig DS; Holmes RK; Schoolnik GK
    J Biol Chem; 1985 Oct; 260(23):12528-34. PubMed ID: 2413025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thermal stability and intersubunit interactions of cholera toxin in solution and in association with its cell-surface receptor ganglioside GM1.
    Goins B; Freire E
    Biochemistry; 1988 Mar; 27(6):2046-52. PubMed ID: 3378043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of cholera toxin-ganglioside interactions by flow cytometry.
    Lauer S; Goldstein B; Nolan RL; Nolan JP
    Biochemistry; 2002 Feb; 41(6):1742-51. PubMed ID: 11827518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantitative description of the binding of GM1 oligosaccharide by cholera enterotoxin.
    Schafer DE; Thakur AK
    Cell Biophys; 1982 Mar; 4(1):25-40. PubMed ID: 6176326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation.
    Lycke NY
    J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding of cholera toxin B-subunits to derivatives of the natural ganglioside receptor, GM1.
    Lanne B; Schierbeck B; Angström J
    J Biochem; 1999 Jul; 126(1):226-34. PubMed ID: 10393343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin.
    Masserini M; Freire E; Palestini P; Calappi E; Tettamanti G
    Biochemistry; 1992 Mar; 31(8):2422-6. PubMed ID: 1311601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The binding potential between the cholera toxin B-oligomer and its receptor.
    Cai XE; Yang J
    Biochemistry; 2003 Apr; 42(14):4028-34. PubMed ID: 12680755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.